Genital Warts Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition: Human Papillomavirus-Related Carcinoma Interventions: Procedure: Biospecimen Collection; Biological: HPV16 RG1 VLP Vaccine; Other: Questionnaire Administration; Biological: Recombinant Human Papillomavirus Nonavalent Vaccine; Other: Saline Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Evaluation Of The Efficacy Of The Combination Of GLIZIGEN ® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
Conditions: Papilloma Viral Infection; CIN1; LSIL, Low Grade Squamous Intraepithelial Lesion Interventions: Dietary Supplement: Glizigen; Other: Placebo Sponsors: Catalysis SL; Atika Pharma S.L. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2023 Category: Research Source Type: clinical trials